Recent Publications

• Health economics of insomnia therapy: implications for policy.

  Botteman M. Sleep Med. 2009;10(S1):S22-5 (link to PDF) -  Mental and Neurological

  ---

• Cost-effectiveness of eszopiclone for the treatment of adults with primary chronic insomnia.

  Snedecor SJ, Botteman MF, Bojke C, Schaefer K, Barry N, Pickard AS. Sleep 2009;32(6):817-24 (link to PDF) -  Mental and Neurological

  ---

• Transmission-dynamic model to capture the indirect effects of infant vaccination with Prevnar (7-valent pneumococcal conjugate vaccine(PCV7)) in older populations

  Snedecor SJ, Strutton DR, Ciuryla V, Schwartz EJ, Botteman MF. Vaccine 2009;27(34):4694-4703 (link to PDF) -  Infectious Diseases

  ---

• Efficacy of recombinant activated factor VII vs. activated prothrombin complex concentrate for patients suffering from haemophilia complicated with inhibitors: a Bayesian meta-regression.

  Treur MJ, McCracken F, Heeg B, Joshi AV, Botteman MF, De Charro F, Van Hout B. Haemophilia. 2009;15(2):420-436. (link to PDF) -  Other

  ---

• A pharmaco-economic analysis of patients with schizophrenia switching to generic risperidone involving a possible compliance loss

  Treur M, Heeg B, Möller H, Schmeding, van Hout B. BMC Health Serv Res. 2009;9(32):1-9. (link to PDF) -  Mental and Neurological

  ---

• Modelling approaches: the case of schizophrenia.

  Heeg BM, Damen J, Buskens E, Caleo S de Charro F van Hout BA. Pharmacoeconomics 2008;26(8):633-48 (link to PDF) -  Mental and Neurological

  ---

• The cost-effectiveness of atypicals in the UK.

  Heeg B, Buskens E, Botteman M, Caleo S, Ingham M, Damen J, de Charro F, van Hout B. Value Health 2008;11(7):1007-21 (link to PDF)  -  Mental and Neurological

  ---

• Increasing decision-makers' access to economic evaluations: alternative methods of communicating the information

  Thurston SJ, Craig D, Wilson P, Drummond MF. Int J Technol Assess Health Care 2008;24(2):151-7 (link to PDF) -  Other

  ---

• A pharmacoeconomic analysis of compliance gains on antipsychotic medications.

  Damen J, Thuresson PO, Heeg B, Lothgren M. Appl Health Econ Health Policy 2008;6(4):189-97 (link to PDF) -  Mental and Neurological

  ---

• Cost-effectiveness and budget impact of long-acting risperidone in Portugal: a modeling exercise.

  Heeg BM, Antunes J, Figueira ML, Jara JM, Marques Teixeira J, Palha AP, Vaz Serra A, Buskens E, Caleo S, Van Hout BA. Curr Med Res Opin. 2008;24(2):349-58. (link to PDF) -  Mental and Neurological

  ---